Oseni
Generic: alogliptin-pioglitazone
15MG — Tablet
Hypoglycemics - Oral — 2nd Generation Sulfonylureas
Also known as:
OSENI TAB 12.5-15
OSENI TAB 12.5-30
OSENI TAB 12.5-45
OSENI TAB 25-15MG
OSENI TAB 25-30MG
OSENI TAB 25-45MG
Compare Prices
Coverage by Insurer
Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
AmeriHealth Caritas NC
10 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
AmeriHealth Caritas Next Silver Essential + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Silver Premier + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Silver Off-Marketplace Low + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Bronze Signature + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Silver Signature + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Gold Premier + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Bronze Premier + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Bronze Essential + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Silver Off-Marketplace High + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
|
AmeriHealth Caritas Next Gold Signature + No Referrals
via alogliptin-pioglitazone |
Tier 2 - Generic | — | — | ✓ | QL |
Blue Cross Blue Shield Federal
3 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
BCBS Federal Basic Option 2026
via alogliptin-pioglitazone |
Tier 1 - Generic | — | — | — | None |
|
BCBS Federal Focus 2026
via alogliptin-pioglitazone |
Tier 1 - Generic | — | — | — | None |
|
BCBS Federal Standard Option 2026
via alogliptin-pioglitazone |
Tier 1 - Generic | — | — | — | None |
NC Medicaid PDL
2 plansNC State Health Plan
3 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
NC State Health Plan - 80/20 Plus PPO 2026
via alogliptin-pioglitazone |
Not Covered | — | — | — | None |
|
NC State Health Plan - 70/30 Standard PPO 2026
via alogliptin-pioglitazone |
Not Covered | — | — | — | None |
|
NC State Health Plan - HDHP 2026
via alogliptin-pioglitazone |
Not Covered | — | — | — | None |